Company: BIAF
Filing Date: 2025-04-15
Form Type: DRS
Source: 0001641172-25-004915
Chunk: 3

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-04-15
Form: DRS
Chunk 3
---
 purchase of shares of Common Stock in this offering would result in such purchaser, together with its affiliates and certain related parties, beneficially owning more than 4.99% (or, at the election of the purchaser, 9.99%) of our outstanding Common Stock following the consummation of this offering, the opportunity to purchase, in lieu of the shares of our Common Stock that would otherwise result in the purchaser’s beneficial ownership exceeding 4.99% (or, at the election of the purchaser, 9.99%), pre-funded warrants (the “Pre-Funded Warrants”) each to purchase one and one-half shares of Common Stock at an exercise price of $0.007 per share. Each Pre-Funded Warrant is being issued together with one April 2025 Warrant to purchase one and one-half share of Common Stock. The assumed combined public offering price for each Pre-Funded Warrant and accompanying April 2025 Warrant will be equal to the public offering price per share of Common Stock and accompanying April 2025 Warrant in this offering, minus $0.007. Each Pre-Funded Warrant will be exercisable upon issuance and may be exercised at any time until all of the Pre-Funded Warrants are exercised in full.

This prospectus also relates to the offering of the shares of Common Stock issuable upon exercise of the April 2025 Warrants, Pre-Funded Warrants and Placement Agent Warrants (as defined herein).

For each Pre-Funded Warrant sold, the number of shares of Common Stock sold will be reduced on a one-for-one basis. The shares of Common Stock and/or Pre-Funded Warrants and the accompanying April 2025 Warrants can only be purchased together in this offering but will be issued separately and will be immediately separable upon issuance.

This offering will terminate on [___], 2025, unless we decide to terminate the offering (which we may do at any time in our discretion) prior to that date. We will have one closing for all the securities purchased in this offering. The combined public offering price per share of Common Stock (or Pre-Funded Warrant) and accompanying April 2025 Warrant will be fixed for the duration of this offering.

We have engaged WallachBeth Capital, LLC (the “Placement Agent”), to act as our exclusive placement agent in connection with this offering. The Placement Agent has agreed to use its reasonable best efforts to arrange for the sale of the securities offered by this prospectus. The Placement Agent is